Hills Bank & Trust’s Gilead Sciences GILD Stock Holding History

Hills Bank & Trust’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$172K	Buy	1,362 +567	+71%	+$74.7K	0.01%	327
2026 Q1	$111K	Buy	+795	New	+$111K	0.01%	341
2025 Q2	–	Sell	-1,165	Closed	-$131K	–	315
2025 Q1	$131K	Buy	+1,165	New	+$120K	0.01%	281
2017 Q3	–	Sell	-18,254	Closed	-$1.29M	–	131
2017 Q2	$1.29M	Sell	18,254 -148	-0.8%	-$9.85K	0.42%	55
2017 Q1	$1.25M	Sell	18,402 -261	-1%	-$18.4K	0.42%	54
2016 Q4	$1.34M	Sell	18,663 -430	-2%	-$32K	0.47%	49
2016 Q3	$1.51M	Buy	19,093 +10,185	+114%	+$827K	0.55%	47
2016 Q2	$743K	Buy	8,908 +1,378	+18%	+$122K	0.27%	75
2016 Q1	$692K	Buy	7,530 +1,240	+20%	+$112K	0.26%	75
2015 Q4	$636K	Buy	6,290 +3,480	+124%	+$362K	0.24%	66
2015 Q3	$276K	Buy	+2,810	New	+$312K	0.11%	74

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Hills Bank & Trust's GILD Position: Q2 2026 in Review

Hills Bank & Trust increased its Gilead Sciences (GILD) stake by 71% in Q2 2026, buying an estimated $74.7K and bringing the position to 1,362 shares worth $172K. The position accounts for 0.01% of the portfolio, ranked #327.

Hills Bank & Trust first reported a position in GILD in Q3 2015 and has held it in 11 quarters since. The position peaked at $1.51M in Q3 2016. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Hills Bank & Trust held 1,362 shares of Gilead Sciences worth $172K as of Q2 2026.
Hills Bank & Trust bought 567 Gilead Sciences shares in Q2 2026, an estimated $74.7K.
Gilead Sciences made up 0.01% of Hills Bank & Trust's portfolio in Q2 2026, its #327 holding.
Hills Bank & Trust first reported a position in Gilead Sciences in Q3 2015 and has held it in 11 quarters since.
Hills Bank & Trust's Gilead Sciences position peaked at $1.51M in Q3 2016.
2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Hills Bank & Trust's 13F filing for Q2 2026, filed 10 Aug 2026.